Veranova: A CDMO that manages complexity with confidence.
01 1Veranova, L.P.
02 1Cipla Ltd.
03 1Heraeus Precious Metals GmbH & Co. KG
04 1Hetero Labs Limited
05 1Hubei Haosun Pharmaceutical Co., Ltd.
06 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
07 1Qilu Pharmaceutical Co. Ltd.
08 1SHILPA PHARMA LIFESCIENCES LIMITED
09 1Sicor de Mexico S.A. de C.V
10 1Umicore Argentina S.A.
01 9Oxaliplatin
02 1oxaliplatin
01 3China
02 2Germany
03 3India
04 1Mexico
05 1U.S.A
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 49812-0075
Start Marketing Date : 2003-11-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7649
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (200mg/200mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54875-0006
Start Marketing Date : 2013-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0083
Start Marketing Date : 2005-01-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14778-0404
Start Marketing Date : 2011-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0017
Start Marketing Date : 2007-05-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.5kg/.5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67184-0007
Start Marketing Date : 2019-11-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82920-704
Start Marketing Date : 2022-08-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-0700
Start Marketing Date : 2018-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72659-865
Start Marketing Date : 2018-01-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Oxaliplatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxaliplatin, including repackagers and relabelers. The FDA regulates Oxaliplatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxaliplatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxaliplatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxaliplatin supplier is an individual or a company that provides Oxaliplatin active pharmaceutical ingredient (API) or Oxaliplatin finished formulations upon request. The Oxaliplatin suppliers may include Oxaliplatin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxaliplatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxaliplatin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxaliplatin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxaliplatin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxaliplatin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxaliplatin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxaliplatin suppliers with NDC on PharmaCompass.
We have 10 companies offering Oxaliplatin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
